According to Dynavax Technologies 's latest financial reports the company's current revenue (TTM) is $0.23 B. In 2022 the company made a revenue of $0.72 B an increase over the years 2021 revenue that were of $0.43 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.23 B | -67.86% |
2022 | $0.72 B | 64.45% |
2021 | $0.43 B | 844% |
2020 | $46.55 M | 32.18% |
2019 | $35.21 M | 329.6% |
2018 | $8.19 M | 2407.03% |
2017 | $0.32 M | -97.04% |
2016 | $11.04 M | 227.98% |
2015 | $3.36 M | -59.65% |
2014 | $8.34 M | -25.84% |
2013 | $11.25 M | 15.82% |
2012 | $9.71 M | -55.06% |
2011 | $21.61 M | -9.75% |
2010 | $23.95 M | -40.6% |
2009 | $40.31 M | 8.69% |
2008 | $37.09 M | 163.21% |
2007 | $14.09 M | 190.76% |
2006 | $4.84 M | -66.93% |
2005 | $14.65 M | -1.06% |
2004 | $14.81 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Pfizer PFE | $58.49 B | 25,083.40% | ๐บ๐ธ USA |
Amgen AMGN | $28.19 B | 12,036.01% | ๐บ๐ธ USA |
Biogen BIIB | $9.83 B | 4,134.30% | ๐บ๐ธ USA |
Gilead Sciences GILD | $27.11 B | 11,573.21% | ๐บ๐ธ USA |
Merck MRK | $60.11 B | 25,779.53% | ๐บ๐ธ USA |
AstraZeneca AZN | $45.81 B | 19,621.98% | ๐ฌ๐ง UK |
GlaxoSmithKline GSK | $37.84 B | 16,194.30% | ๐ฌ๐ง UK |
Agenus
AGEN | $0.15 B | -32.71% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $15.84 B | 6,721.82% | ๐ฎ๐ฑ Israel |